Fund: FTBDF

Franklin Templeton - Franklin Biotechnology Discovery Fund A(acc)USD - 4912
LU0109394709
03-04-2000
Equity
Equity Sectors - Health Care
Franklin Templeton Investment Funds
Franklin Advisers, Inc.
Evan McCulloch
USD
1,000
5.75%
EIC Fund Rating (2020)
Rok Rated portolio Ref. ccy Rating category Rf (p.a.) Rm (p.a.) Return (p.a.) Correlation Beta Alpha (p.a.) Rank Stars
2020 FTBDF USD EQ-SEC-HC 0.3675% 26.57% 38.12% 0.92 1.21 6.18% 3/8
2019 FTBDF USD EQ-SEC-HC 2.1319% 23.40% 35.60% 0.88 1.59 -0.45% 5/7
2018 FTBDF USD EQ-SEC-HC 1.8344% -6.34% -17.33% 0.82 1.41 -7.59% 7/8
2017 FTBDF USD EQ-SEC-HC 1.0263% 21.62% 18.79% 0.77 1.81 -19.55% 8/8
2016 FTBDF USD EQ-SEC-HC 0.3901% -9.83% -15.55% 0.77 1.69 1.31% 5/11
2015 FTBDF USD EQ-SEC-HC 0.1342% 11.89% 10.97% 0.77 1.53 -4.77% 8/11
2014 FTBDF USD EQ-SEC-HC 0.0923% 31.35% 59.54% 0.81 1.88 0.69% 5/11
38.8500
22-04-2024
0.9091%
Quick compare
1M 3M 6M 9M 1R 3R p.a. 5R p.a. 7R p.a. 10R p.a. od vnizku p.a.
Výkonnosť fondu -8.89% -1.04% 22.71% 13.73% 11.93% -3.24% 5.78% 4.01% 4.92% N/A
Priemerná výkonnosť (36 meraní) 0.15% -3.12% 1.29% 3.49% 2.91%
Volatilita od priemernej výkonnosti 9.29% 29.30% 8.99% 6.57% 5.24%
Rozloženie aktív
Long Short Net
Stock 96.90% 96.90%
Bond
Other 0.61% 0.61%
Cash 2.49% 2.49%
Veľkosť fondu
Aktíva14,251 mil.
Počet akcíí93
Počet dlhopisov0
Nákladovosť fondu
Priebež. popl.1.81
 z toho Mng. popl.1.50
Výk. prémia
Trans. popl.0.04
Výnosovosť fondu
Dividenda
Dividendový výnos
Rozhodný dátum
Frekvencia výplaty
Akciové portfólio
Giant 2.75%
Large 22.36%
Medium 19.43%
Small 15.58%
Micro 32.33%
P/E16.58%
P/BV4.29%
Sektorové rozloženie
Basic Materials 1.29%
Healthcare 91.22%
Dlhopisové portfólio
Corporate 0.53
Derivatives 2.49
Výnos do splatnosti p.a.
Modifikovaná durácia
Kreditné rozloženie
AAA 0.00
AA 0.00
A 0.00
BBB 0.00
BB 0.00
B 0.00
Below B 0.00
Not Rated 100.00
Regionálne rozloženie
United States 84.51%
Canada 1.03%
Latin America
United Kingdom 3.61%
Eurozone 3.77%
Europe - ex Euro 3.99%
Europe - Emerging
Africa
Middle East
Japan
Australasia
Asia - Developed
Asia - Emerging
Emerging Market
Developed Country 96.90%
Not Classified
Top 10 pozícií
SpoločnosťSubsektorVáha SpoločnosťSubsektorVáha
Amgen Inc Healthcare 6.58% Regeneron Pharmaceuticals Inc Healthcare 6.24%
Vertex Pharmaceuticals Inc Healthcare 5.2% Ascendis Pharma A/S ADR Healthcare 3.99%
Gilead Sciences Inc Healthcare 2.92% Intra-Cellular Therapies Inc Healthcare 2.81%
Biogen Inc Healthcare 2.8% AstraZeneca PLC ADR Healthcare 2.75%
Jazz Pharmaceuticals PLC Healthcare 2.55% Merus NV Healthcare 2.35%